Crescendo Aims To Increase IO Share Of Voice With Humabody Platform

Peter Pack
Peter Pack, CEO of Crescendo Biologics, talks to Scrip at BIO-Europe Spring 2018 • Source: Scrip/LEllis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immuno-oncology

More from Anticancer